ALR Technologies
announced that it has upgraded its Health-e-Connect Diabetes Management System
so that it may facilitate online, insulin dosing consultations for physicians.
Through the Health-e-Connect System, prescribing physicians will have the
option to get a second opinion online on their recommended insulin dose. The
second opinion is from an independent consulting endocrinologist.
The consulting
endocrinologist gives the dosing opinion based on a review of actual blood
glucose data from the patient’s meter along with other pertinent factors
necessary for prescribing. Examples of additional factors include current
insulin dosage, height, and weight. ALRT’s Health-e-Connect Diabetes Management
System is a practical aid for assisting providers with an online second opinion
as patient blood glucose data and other key information can be made available
online to the consulting specialist. The result provides an easy method to allow
a prescribing clinician to regularly adjust a patient’s insulin dose without an
office visit. The Insulin Dose Adjustment Consultation (IDAC) system is in the
final testing phase and is expected to be available to the customer in
mid-June.
Adjustments in
patient insulin doses offers the potential for their insulin dose to be
optimized on a regular basis, which may slow the progression of some
comorbidities associated with diabetes. Additionally, with the monitoring and
care facilitation embedded in the Health-e-Connect System, patients may also
find it easier to follow their prescribed insulin regimen. For payers, the
widespread adoption of intensive blood glucose management would be a key tool
in helping to manage the escalating costs of diabetes care without the cost of
additional office visits.
ALRT’s CEO Sidney
Chan said: “The clinical practice of diabetes would be improved through a
system that ensures patients are more likely to be at their optimal dose of
insulin. Intensive blood glucose management has been shown to be effective and
some patients who are lucky enough to be treated by high-end endocrinologists
have access to its benefits. We want to bring this high level of intensive
treatment to primary care physicians and to a much broader population of
patients.”
ALR Technologies is
a medical device company providing remote monitoring and care facilitation for
patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA
compliant Health-e-Connect System that collects data from blood glucose meters
and uploads to a secure website.
For more information
on the company visit www.alrt.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.netALR Technologies, Inc.
(ALRT) Online Insulin Dosing Upgrade Enhances Patient Care
ALR Technologies
announced that it has upgraded its Health-e-Connect Diabetes Management System
so that it may facilitate online, insulin dosing consultations for physicians.
Through the Health-e-Connect System, prescribing physicians will have the
option to get a second opinion online on their recommended insulin dose. The
second opinion is from an independent consulting endocrinologist.
The consulting
endocrinologist gives the dosing opinion based on a review of actual blood
glucose data from the patient’s meter along with other pertinent factors
necessary for prescribing. Examples of additional factors include current
insulin dosage, height, and weight. ALRT’s Health-e-Connect Diabetes Management
System is a practical aid for assisting providers with an online second opinion
as patient blood glucose data and other key information can be made available
online to the consulting specialist. The result provides an easy method to allow
a prescribing clinician to regularly adjust a patient’s insulin dose without an
office visit. The Insulin Dose Adjustment Consultation (IDAC) system is in the
final testing phase and is expected to be available to the customer in
mid-June.
Adjustments in
patient insulin doses offers the potential for their insulin dose to be
optimized on a regular basis, which may slow the progression of some
comorbidities associated with diabetes. Additionally, with the monitoring and
care facilitation embedded in the Health-e-Connect System, patients may also
find it easier to follow their prescribed insulin regimen. For payers, the
widespread adoption of intensive blood glucose management would be a key tool
in helping to manage the escalating costs of diabetes care without the cost of
additional office visits.
ALRT’s CEO Sidney
Chan said: “The clinical practice of diabetes would be improved through a
system that ensures patients are more likely to be at their optimal dose of
insulin. Intensive blood glucose management has been shown to be effective and
some patients who are lucky enough to be treated by high-end endocrinologists
have access to its benefits. We want to bring this high level of intensive
treatment to primary care physicians and to a much broader population of
patients.”
ALR Technologies is
a medical device company providing remote monitoring and care facilitation for
patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA
compliant Health-e-Connect System that collects data from blood glucose meters
and uploads to a secure website.
For more information
on the company visit www.alrt.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment